{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:31:36Z","timestamp":1770899496321,"version":"3.50.1"},"reference-count":100,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2021,11,23]]},"DOI":"10.18632\/oncotarget.28077","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T14:39:23Z","timestamp":1631803163000},"page":"2421-2433","source":"Crossref","is-referenced-by-count":23,"title":["Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma"],"prefix":"10.18632","volume":"12","author":[{"given":"Arvin","family":"Medhat","sequence":"first","affiliation":[{"name":"Department of Molecular Cell Biology, Azad University, North Unit, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Arzumanyan","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Feitelson","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/s0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan","volume":"2","author":"Chien","year":"1981","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/MCB.00205-13","article-title":"Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis","volume":"3","author":"Ni","year":"2013","journal-title":"Mol Cell Biol"},{"key":"3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1517\/14728222.2014.867947","article-title":"The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease","volume":"1","author":"Arzumanyan","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmarks analysis","volume":"1","author":"Munger","year":"2014","journal-title":"Cell Host Microbe"},{"key":"5","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","article-title":"HBV-Induced Immune Imbalance in the Development of HCC","volume":"1","author":"Tian","year":"2019","journal-title":"Front Immunol"},{"key":"6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.21037\/atm.2017.03.69","article-title":"Alpha-interferon treatment in hepatitis B","volume":"5","author":"Ahmed","year":"2017","journal-title":"Ann Transl Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbrc.2016.03.082","article-title":"HBsAg blocks TYPE I IFN induced up-regulation of A3G through inhibition of STAT3","volume":"47","author":"Tan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"8","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1016\/j.celrep.2019.11.041","article-title":"Type-I-IFN-Stimulated Gene TRIM5\u03b3 Inhibits HBV Replication by Promoting HBx Degradation","volume":"2","author":"Cheng","year":"2019","journal-title":"Cell Rep"},{"key":"9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1172\/JCI11100","article-title":"The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance","volume":"10","author":"Omata","year":"2001","journal-title":"J Clin Invest"},{"key":"10","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s12072-020-10116-z","article-title":"HBx mutations emerged during antiviral therapy: a new face of a multifaceted HBV protein?","volume":"1","author":"Hou","year":"2020","journal-title":"Hepatol Int"},{"key":"11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jvh.12479","article-title":"Identification of FDA-approved drugs that target hepatitis B virus transcription","volume":"2","author":"Kootstra","year":"2016","journal-title":"J Viral Hepat"},{"key":"12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/v12080851","article-title":"Advances with RNAi-Based Therapy for Hepatitis B Virus Infection","volume":"1","author":"Arbuthnot","year":"2020","journal-title":"Viruses"},{"key":"13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","article-title":"Strategies to inhibit entry of HBV and HDV into hepatocytes","volume":"14","author":"Zoulim","year":"2014","journal-title":"Gastroenterology"},{"key":"14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"1","author":"Bertoletti","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1021\/acsinfecdis.8b00269","article-title":"Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors","volume":"5","author":"Chang","year":"2019","journal-title":"ACS Infect Dis"},{"key":"16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B virus genome recycling andsecondary infection events maintain stable cccDNA levels","volume":"6","author":"Protzer","year":"2018","journal-title":"J Hepatol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"6","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/v13010114","article-title":"Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator","volume":"1","author":"Schinazi","year":"2021","journal-title":"Viruses"},{"key":"19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"5","author":"Protzer","year":"2011","journal-title":"J Hepatol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1128\/JVI.67.3.1218-1226.1993","article-title":"The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks","volume":"6","author":"Miller","year":"1993","journal-title":"J Virol"},{"key":"21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/infdis\/172.3.713","article-title":"X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis","volume":"17","author":"Blumberg","year":"1995","journal-title":"J Infect Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/14789450.2014.861745","article-title":"Using proteomics to identify the HBx interactome in hepatitis B virus: how can this inform the clinic?","volume":"1","author":"Huang","year":"2014","journal-title":"Expert Rev Proteomics"},{"key":"23","doi-asserted-by":"publisher","first-page":"a021402","DOI":"10.1101\/cshperspect.a021402","article-title":"Hepatitis B Virus X and Regulation of Viral Gene Expression","volume":"6","author":"Bouchard","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.27360","article-title":"Technical standards for hepatitis B virus X protein (HBx) research","volume":"6","author":"Siddiqui","year":"2015","journal-title":"Hepatology"},{"key":"25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1128\/JVI.43.2.687-696.1982","article-title":"Core particles of hepatitis B virus and ground squirrel hepatitis virus. I. Relationship between hepatitis B core antigen- and ground squirrel hepatitis core antigen-associated polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and tryptic peptide mapping","volume":"4","author":"Robinson","year":"1982","journal-title":"J Virol"},{"key":"26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/infdis\/164.6.1104","article-title":"Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection","volume":"16","author":"Feitelson","year":"1991","journal-title":"J Infect Dis"},{"key":"27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0042-6822(90)90491-9","article-title":"Monoclonal antibodies raised to purified woodchuck hepatitis virus core antigen particles demonstrate X antigen reactivity","volume":"17","author":"Phimister","year":"1990","journal-title":"Virology"},{"key":"28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/acsinfecdis.9b00249","article-title":"Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New Approaches","volume":"5","author":"David","year":"2019","journal-title":"ACS Infect Dis"},{"key":"29","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1128\/JVI.79.7.4238-4245.2005","article-title":"Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death","volume":"7","author":"Strubin","year":"2005","journal-title":"J Virol"},{"key":"30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"53","author":"Strubin","year":"2016","journal-title":"Nature"},{"key":"31","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"10","author":"Levrero","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.virusres.2008.09.006","article-title":"Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription","volume":"13","author":"Lee","year":"2009","journal-title":"Virus Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"13","author":"Levrero","year":"2006","journal-title":"Gastroenterology"},{"key":"34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12864-017-3561-5","article-title":"Genome-wide identification of direct HBx genomic targets","volume":"1","author":"Levrero","year":"2017","journal-title":"BMC Genomics"},{"key":"35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coviro.2018.01.007","article-title":"Role of HBx in hepatitis B virus persistence and its therapeutic implications","volume":"3","author":"Bouchard","year":"2018","journal-title":"Curr Opin Virol"},{"key":"36","first-page":"545","article-title":"A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state","volume":"3","author":"Hofschneider","year":"1988","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.3748\/wjg.v20.i20.6236","article-title":"Role of hepatitis B virus DNA integration in human hepatocarcinogenesis","volume":"2","author":"Kawada","year":"2014","journal-title":"World J Gastroenterol"},{"key":"38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2006.11.010","article-title":"Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis","volume":"25","author":"Lee","year":"2007","journal-title":"Cancer Lett"},{"key":"39","doi-asserted-by":"publisher","first-page":"25075","DOI":"10.18632\/oncotarget.25308","article-title":"Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers","volume":"9","author":"Aikata","year":"2018","journal-title":"Oncotarget"},{"key":"40","first-page":"4971","article-title":"Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer","volume":"5","author":"Feitelson","year":"1991","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1128\/JVI.70.7.4558-4566.1996","article-title":"Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins","volume":"7","author":"Schneider","year":"1996","journal-title":"J Virol"},{"key":"42","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3748\/wjg.15.3099","article-title":"Molecular characteristics and stages of chronic hepatitis B virus infection","volume":"1","author":"Shi","year":"2009","journal-title":"World J Gastroenterol"},{"key":"43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1101\/gad.856201","article-title":"The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis","volume":"1","author":"Kim","year":"2001","journal-title":"Genes Dev"},{"key":"44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1099\/vir.0.19650-0","article-title":"Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin","volume":"8","author":"Feitelson","year":"2004","journal-title":"J Gen Virol"},{"key":"45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2893.2004.00555.x","article-title":"Activation of fibronectin gene expression by hepatitis B virus x antigen","volume":"1","author":"Feitelson","year":"2004","journal-title":"J Viral Hepat"},{"key":"46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2008.12.010","article-title":"Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease","volume":"28","author":"Lian","year":"2009","journal-title":"Cancer Lett"},{"key":"47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0168-8278(99)80172-x","article-title":"Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein","volume":"3","author":"Lee","year":"1999","journal-title":"J Hepatol"},{"key":"48","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1128\/jvi.74.11.5266-5272.2000","article-title":"Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice","volume":"7","author":"Slagle","year":"2000","journal-title":"J Virol"},{"key":"49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.24675","article-title":"Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice","volume":"5","author":"He","year":"2012","journal-title":"Hepatology"},{"key":"50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.micpath.2019.01.004","article-title":"Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma","volume":"12","author":"Singh","year":"2019","journal-title":"Microb Pathog"},{"key":"51","first-page":"2991","article-title":"Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization","volume":"1","author":"Baeuerle","year":"1992","journal-title":"EMBO J"},{"key":"52","doi-asserted-by":"publisher","first-page":"16969","DOI":"10.1074\/jbc.M011263200","article-title":"The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade","volume":"27","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"53","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1099\/vir.0.83214-0","article-title":"The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin","volume":"8","author":"Feitelson","year":"2007","journal-title":"J Gen Virol"},{"key":"54","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1128\/JVI.02590-08","article-title":"Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore","volume":"8","author":"Bouchard","year":"2009","journal-title":"J Virol"},{"key":"55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1099\/0022-1317-82-1-171","article-title":"Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B","volume":"8","author":"Feitelson","year":"2001","journal-title":"J Gen Virol"},{"key":"56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1046\/j.1365-2893.2001.00308.x","article-title":"Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases","volume":"8","author":"Cho","year":"2001","journal-title":"J Viral Hepat"},{"key":"57","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.3892\/ol.2020.11404","article-title":"Effect of HBx on inflammation and mitochondrial oxidative stress in mouse hepatocytes","volume":"1","author":"Li","year":"2020","journal-title":"Oncol Lett"},{"key":"58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3748\/wjg.14.574","article-title":"Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice","volume":"1","author":"Kremsdorf","year":"2008","journal-title":"World J Gastroenterol"},{"key":"59","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jmb.2010.02.016","article-title":"HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways","volume":"39","author":"Kim","year":"2010","journal-title":"J Mol Biol"},{"key":"60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42826-020-00037-1","article-title":"Relevance of reactive oxygen species in liver disease observed in transgenic mice expressing the hepatitis B virus X protein","volume":"3","author":"Yu","year":"2020","journal-title":"Lab Anim Res"},{"key":"61","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-10-3951","article-title":"Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?","volume":"7","author":"Feitelson","year":"2011","journal-title":"Cancer Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ijc.30553","article-title":"HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K\/AKT signal pathway","volume":"14","author":"Li","year":"2017","journal-title":"Int J Cancer"},{"key":"63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3892\/ol.2021.12651","article-title":"NAMPT promotes hepatitis B virus replication and liver cancer cell proliferation through the regulation of aerobic glycolysis","volume":"2","author":"Mo","year":"2021","journal-title":"Oncol Lett"},{"key":"64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhep.2020.12.034","article-title":"Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter","volume":"7","author":"Riedl","year":"2021","journal-title":"J Hepatol"},{"key":"65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/hep.1840140106","article-title":"HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis","volume":"1","author":"Feitelson","year":"1991","journal-title":"Hepatology"},{"key":"66","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1158\/0008-5472.CAN-07-0529","article-title":"Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4\/6-pRb-E2F1 pathway","volume":"6","author":"Jang","year":"2007","journal-title":"Cancer Res"},{"key":"67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11010-013-1769-5","article-title":"Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt\/\u03b2-catenin pathway","volume":"38","author":"Huang","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2005.07.009","article-title":"Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma","volume":"23","author":"Feitelson","year":"2006","journal-title":"Cancer Lett"},{"key":"69","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/ijc.11254","article-title":"Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis","volume":"10","author":"Ohgaki","year":"2003","journal-title":"Int J Cancer"},{"key":"70","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1742-4658.2012.08514.x","article-title":"Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation","volume":"27","author":"Kumar","year":"2012","journal-title":"FEBS J"},{"key":"71","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/onc.2016.82","article-title":"Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma","volume":"3","author":"Lee","year":"2016","journal-title":"Oncogene"},{"key":"72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","article-title":"Epigenetic modulation in chronic hepatitis B virus infection","volume":"4","author":"Dandri","year":"2020","journal-title":"Semin Immunopathol"},{"key":"73","doi-asserted-by":"publisher","first-page":"24430","DOI":"10.1038\/srep24430","article-title":"Hepatitis B virus X protein (HBx)-induced abnormalities of nucleic acid metabolism revealed by (1)H-NMR-based metabonomics","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep"},{"key":"74","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1440-1746.2010.06546.x","article-title":"Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma","volume":"2","author":"Kew","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"75","doi-asserted-by":"publisher","first-page":"9555","DOI":"10.1073\/pnas.1400604111","article-title":"HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators","volume":"11","author":"Kim","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"76","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s13277-013-1372-0","article-title":"Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection","volume":"3","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"77","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s00705-017-3462-6","article-title":"Modulation of Wnt signaling pathway by hepatitis B virus","volume":"16","author":"Ijaz","year":"2017","journal-title":"Arch Virol"},{"key":"78","doi-asserted-by":"publisher","first-page":"e46082","DOI":"10.1371\/journal.pone.0046082","article-title":"MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1","volume":"7","author":"Liao","year":"2012","journal-title":"PLoS One"},{"key":"79","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3760\/cma.j.issn.1007-3418.2018.07.002","article-title":"[The effect of miR-155 on HBV replication and PTEN expression","volume":"2","author":"Zhou","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"80","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-10-1938","article-title":"The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence","volume":"7","author":"Sun","year":"2010","journal-title":"Cancer Res"},{"key":"81","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/v12070746","article-title":"The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways","volume":"1","author":"Kramvis","year":"2020","journal-title":"Viruses"},{"key":"82","doi-asserted-by":"publisher","first-page":"a024935","DOI":"10.1101\/cshperspect.a024935","article-title":"Viral hepatitis B: clinical and epidemiological characteristics","volume":"4","author":"Thompson","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"83","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3389\/fimmu.2019.02308","article-title":"Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response","volume":"1","author":"Lu","year":"2019","journal-title":"Front Immunol"},{"key":"84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2018.11.006","article-title":"5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice","volume":"16","author":"Zhang","year":"2019","journal-title":"Antiviral Res"},{"key":"85","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3390\/jcm9103187","article-title":"New Approaches to the Treatment of Chronic Hepatitis B","volume":"9","author":"Karayiannis","year":"2020","journal-title":"J Clin Med"},{"key":"86","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1038\/s41467-019-11173-1","article-title":"Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction","volume":"1","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"key":"87","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7150\/thno.20047","article-title":"A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway","volume":"8","author":"Xia","year":"2018","journal-title":"Theranostics"},{"key":"88","unstructured":"https:\/\/clinicaltrials.gov."},{"key":"89","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx","volume":"7","author":"Zhang","year":"2021","journal-title":"J Hepatol"},{"key":"90","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-020-00662-x","article-title":"HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice","volume":"2","author":"Chen","year":"2020","journal-title":"J Biomed Sci"},{"key":"91","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.virusres.2005.12.012","article-title":"Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice","volume":"11","author":"Park","year":"2006","journal-title":"Virus Res"},{"key":"92","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction","volume":"7","author":"Koike","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"93","first-page":"271","article-title":"[Application of radiolabeled anti-HBx monoclonal antibody for HCC targeting therapy]","volume":"7","author":"Liu","year":"1996","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"94","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/medsci6030079","article-title":"GutLiver Axis: How Do Gut Bacteria Influence the Liver?","volume":"6","author":"Zopf","year":"2018","journal-title":"Med Sci (Basel)"},{"key":"95","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3389\/fmicb.2017.02222","article-title":"Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Microbiol"},{"key":"96","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/cam4.3045","article-title":"Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"97","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1002\/cam4.1550","article-title":"On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B","volume":"7","author":"Mohamadkhani","year":"2018","journal-title":"Cancer Med"},{"key":"98","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neo.2021.04.004","article-title":"Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice","volume":"2","author":"Feitelson","year":"2021","journal-title":"Neoplasia"},{"key":"99","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"14","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"100","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/cld.829","article-title":"Nonliver Comorbidities in Patients With Chronic Hepatitis B","volume":"1","author":"Nguyen","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T16:46:46Z","timestamp":1637686006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":100,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,7,9]]}},"alternative-id":["28077"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28077","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}